Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

RXi Pharmaceuticals Corp Company Profile (NASDAQ:RXII)

Consensus Ratings for RXi Pharmaceuticals Corp (NASDAQ:RXII) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.58 (816.67% upside)

Analysts' Ratings History for RXi Pharmaceuticals Corp (NASDAQ:RXII)
Show:
DateFirmActionRatingPrice TargetActions
5/1/2015ZacksReiterated RatingBuy -> Buy$0.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015HC WainrightLower Price TargetBuy$9.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2014HC WainrightSet Price TargetBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014LaidlawInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014HC WainrightInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)